CDKN2B and breast cancer: In breast cancer, Cbl-b binds to the proline rich region of Smad3 and prevents the protein from translocating into the nucleus to inhibit the transcription of tumor suppressor genes downstream of the TGF-β pathway, including p21Cip1 and p15INK4b [27].